ZA202210745B - Method for the production of aav - Google Patents

Method for the production of aav

Info

Publication number
ZA202210745B
ZA202210745B ZA2022/10745A ZA202210745A ZA202210745B ZA 202210745 B ZA202210745 B ZA 202210745B ZA 2022/10745 A ZA2022/10745 A ZA 2022/10745A ZA 202210745 A ZA202210745 A ZA 202210745A ZA 202210745 B ZA202210745 B ZA 202210745B
Authority
ZA
South Africa
Prior art keywords
aav
production
Prior art date
Application number
ZA2022/10745A
Other languages
English (en)
Inventor
Juliana Coronel
Silke Wissing
Original Assignee
Cevec Pharmaceuticals Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=73597941&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA202210745(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cevec Pharmaceuticals Gmbh filed Critical Cevec Pharmaceuticals Gmbh
Publication of ZA202210745B publication Critical patent/ZA202210745B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M29/00Means for introduction, extraction or recirculation of materials, e.g. pumps
    • C12M29/10Perfusion
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/14011Parvoviridae
    • C12N2750/14111Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/14011Parvoviridae
    • C12N2750/14111Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/14011Parvoviridae
    • C12N2750/14111Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14151Methods of production or purification of viral material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/14011Parvoviridae
    • C12N2750/14111Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14151Methods of production or purification of viral material
    • C12N2750/14152Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Sustainable Development (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
ZA2022/10745A 2020-11-25 2022-09-28 Method for the production of aav ZA202210745B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20209811.7A EP4006141A1 (en) 2020-11-25 2020-11-25 Method for the production of aav
PCT/EP2021/082615 WO2022112218A1 (en) 2020-11-25 2021-11-23 Method for the production of aav

Publications (1)

Publication Number Publication Date
ZA202210745B true ZA202210745B (en) 2023-05-31

Family

ID=73597941

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2022/10745A ZA202210745B (en) 2020-11-25 2022-09-28 Method for the production of aav

Country Status (15)

Country Link
US (1) US20240263148A1 (https=)
EP (3) EP4006141A1 (https=)
JP (2) JP7601339B2 (https=)
KR (1) KR102700433B1 (https=)
CN (1) CN116209748A (https=)
AU (1) AU2021388811B2 (https=)
CA (1) CA3174017C (https=)
DK (1) DK4107252T3 (https=)
ES (1) ES3017247T3 (https=)
FI (1) FI4107252T3 (https=)
IL (1) IL296770B2 (https=)
MX (1) MX2022013385A (https=)
PT (1) PT4107252T (https=)
WO (1) WO2022112218A1 (https=)
ZA (1) ZA202210745B (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2022373653A1 (en) * 2021-10-18 2024-05-02 Regeneron Pharmaceuticals, Inc. Eukaryotic cells comprising adenovirus-associated virus polynucleotides
CN119137263A (zh) * 2022-03-07 2024-12-13 奥特吉尼克斯制药公司 改进的分批aav产生系统和方法
EP4532737A1 (en) * 2022-06-03 2025-04-09 F. Hoffmann-La Roche AG Method for producing recombinant aav particles
KR20260048589A (ko) 2023-08-29 2026-04-10 후지필름 가부시키가이샤 바이러스의 제조 방법 및 세포로의 핵산 도입 방법
WO2025171001A1 (en) 2024-02-06 2025-08-14 Regeneron Pharmaceuticals, Inc. Compositions and methods for improved production of aav viral vectors
WO2025168663A1 (en) 2024-02-09 2025-08-14 F. Hoffmann-La Roche Ag Method for producing recombinant adeno-associated viral particles
EP4606816A1 (en) 2024-02-26 2025-08-27 Universitat Autónoma De Barcelona (UAB) Method for production of gene therapy vehicles in mammalian cells
WO2025226558A1 (en) 2024-04-22 2025-10-30 Ultragenyx Pharmaceutical Inc. Multi-step filtration and clarification methods for recombinant adeno-associated virus purification
WO2025252480A1 (en) 2024-06-07 2025-12-11 F. Hoffmann-La Roche Ag Method for purifying plasmid dna
WO2026010979A2 (en) * 2024-07-01 2026-01-08 Genzyme Corporation Perfusion in production bioreactors
US20260022401A1 (en) 2024-07-22 2026-01-22 Hoffmann-La Roche Inc. Novel AAV rep ORFs and Rep polypeptides
WO2026037757A1 (en) 2024-08-13 2026-02-19 F. Hoffmann-La Roche Ag Modified aav particles

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020168342A1 (en) * 1994-11-03 2002-11-14 Cell Genesys, Inc. Novel adenoviral vectors, packaging cell lines, recombinant adenoviruses and methods
US6995006B2 (en) * 1997-09-05 2006-02-07 Targeted Genetics Corporation Methods for generating high titer helper-free preparations of released recombinant AAV vectors
AU764130B2 (en) * 1998-10-27 2003-08-14 Crucell Holland B.V. Improved AAV vector production
US6844192B2 (en) * 2001-06-29 2005-01-18 Wake Forest University Adenovirus E4 protein variants for virus production
WO2017180724A1 (en) * 2016-04-12 2017-10-19 Artemis Biosystems, Inc. Perfusion filtration systems
EP3456822A1 (en) * 2017-09-19 2019-03-20 CEVEC Pharmaceuticals GmbH Inducible aav rep genes
US20220098556A1 (en) * 2019-01-25 2022-03-31 Biogen Ma Inc. Seed culture process for aav production
EP3962536A1 (en) * 2019-04-29 2022-03-09 Voyager Therapeutics, Inc. Systems and methods for producing baculoviral infected insect cells (biics) in bioreactors

Also Published As

Publication number Publication date
DK4107252T3 (da) 2025-03-17
JP2024144435A (ja) 2024-10-11
IL296770B1 (en) 2025-06-01
FI4107252T3 (fi) 2025-03-26
WO2022112218A1 (en) 2022-06-02
CN116209748A (zh) 2023-06-02
EP4596674A2 (en) 2025-08-06
US20240263148A1 (en) 2024-08-08
JP2023518919A (ja) 2023-05-08
KR102700433B1 (ko) 2024-08-30
KR20220164801A (ko) 2022-12-13
EP4596674A3 (en) 2025-10-22
EP4107252B1 (en) 2025-02-19
AU2021388811A1 (en) 2022-11-03
EP4006141A1 (en) 2022-06-01
CA3174017C (en) 2025-05-06
JP7601339B2 (ja) 2024-12-17
EP4107252A1 (en) 2022-12-28
IL296770A (en) 2022-11-01
PT4107252T (pt) 2025-03-14
CA3174017A1 (en) 2022-06-02
MX2022013385A (es) 2022-11-30
AU2021388811B2 (en) 2023-02-23
ES3017247T3 (en) 2025-05-12
IL296770B2 (en) 2025-10-01

Similar Documents

Publication Publication Date Title
ZA202210745B (en) Method for the production of aav
IL304740A (en) A new process
AU2019324126B2 (en) Process for the production of cannabinoids
PL3765433T3 (pl) Sposób wytwarzania glikolu etylenowego
LT3765432T (lt) Etileno glikolio gamybos būdas
PL3766570T3 (pl) Sposób wytwarzania alkoksylanów
GB2595995B (en) Process for Making Levoamphetamine
PL3838381T3 (pl) Sposób wytwarzania tiosiarczanu amonu
GB202007122D0 (en) New process
HUE067878T2 (hu) Eljárás alkilamidotiazolok gyártásához
IL289971A (en) Improved methods for the production of plants
GB201814291D0 (en) Process for the production of gallium radionculides
IL287063A (en) A method for producing a similar structure-biotissue
GB202018476D0 (en) Novel method
GB202007724D0 (en) Novel method
EP3925964A4 (en) METHOD FOR PRODUCTION OF OLIGONUCLEOTIDES
IL316018A (en) IMPROVED PROCESS FOR THE MANUFACTURE OF OSIMERTINIB
PL3489218T3 (pl) Sposób wytwarzania fenyloaminohydroksyantrachinonów
HUP1800125A2 (en) Process for production of iloprost
GB202105113D0 (en) Novel method
EP3995479A4 (en) PROCESS FOR MANUFACTURING ALKANE
IL276724A (en) A process for the production of lipid factors
EP3901361A4 (en) PROCESS FOR PRODUCTION OF RUBBER REINFORCING FIBERS
ES3063036T3 (en) Method for the production of hydrogen
PL3965738T3 (pl) Sposób wytwarzania liposomów